USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months – Healthcare News
The U.S. Food and Drug Administration (USFDA) approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of...
